[
  {
    "title": "Where Will AbbVie Be in 5 Years?",
    "link": "https://www.fool.com/investing/2026/02/26/where-will-abbvie-be-in-5-years/",
    "publisher": "Motley Fool",
    "date": "2026-02-26T20:35:00Z",
    "type": "STORY"
  },
  {
    "title": "IRWD Q4 Earnings and Revenues Fall Shy of Estimates, Stock Tanks",
    "link": "https://finance.yahoo.com/news/irwd-q4-earnings-revenues-fall-154000488.html",
    "publisher": "Zacks",
    "date": "2026-02-26T15:40:00Z",
    "type": "STORY"
  },
  {
    "title": "AbbVie’s CLL Breakthrough And US$380m Build Out Test Valuation",
    "link": "https://finance.yahoo.com/news/abbvie-cll-breakthrough-us-380m-081511039.html",
    "publisher": "Simply Wall St.",
    "date": "2026-02-26T08:15:11Z",
    "type": "STORY"
  },
  {
    "title": "RBC Capital Launches AbbVie (ABBV) Coverage, Expects Shares to Outperform Amid Competitive Fears",
    "link": "https://finance.yahoo.com/news/rbc-capital-launches-abbvie-abbv-022447668.html",
    "publisher": "Insider Monkey",
    "date": "2026-02-26T02:24:47Z",
    "type": "STORY"
  },
  {
    "title": "Aldeyra Therapeutics CEO Highlights Reproxalap Ahead of March 16 FDA Decision at Oppenheimer Conference",
    "link": "https://www.marketbeat.com/instant-alerts/aldeyra-therapeutics-ceo-highlights-reproxalap-ahead-of-march-16-fda-decision-at-oppenheimer-conference-2026-02-25/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "publisher": "MarketBeat",
    "date": "2026-02-25T20:29:45Z",
    "type": "STORY"
  },
  {
    "title": "Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie",
    "link": "https://finance.yahoo.com/news/large-cap-pharma-defensive-ai-145720870.html",
    "publisher": "Investing.com",
    "date": "2026-02-25T14:57:20Z",
    "type": "STORY"
  },
  {
    "title": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More",
    "link": "https://247wallst.com/investing/2026/02/25/here-are-wednesdays-top-wall-street-analyst-research-calls-abbvie-angel-studios-first-solar-ibm-kroger-molson-coors-oracle-workday-and-more/",
    "publisher": "24/7 Wall St.",
    "date": "2026-02-25T12:57:47Z",
    "type": "STORY"
  },
  {
    "title": "AbbVie makes $380 million 'made in the U.S.' move",
    "link": "https://www.thestreet.com/health/abbvie-makes-380-million-made-in-the-u-s-move",
    "publisher": "TheStreet",
    "date": "2026-02-24T21:57:00Z",
    "type": "STORY"
  },
  {
    "title": "How Pipeline Shifts And Competition Are Reshaping The AbbVie (ABBV) Investment Narrative",
    "link": "https://finance.yahoo.com/news/pipeline-shifts-competition-reshaping-abbvie-191126856.html",
    "publisher": "Simply Wall St.",
    "date": "2026-02-24T19:11:26Z",
    "type": "STORY"
  },
  {
    "title": "Is AbbVie Stock Underperforming the Dow?",
    "link": "https://www.barchart.com/story/news/391356/is-abbvie-stock-underperforming-the-dow",
    "publisher": "Barchart",
    "date": "2026-02-24T15:29:40Z",
    "type": "STORY"
  }
]